article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

The Indian Pharmaceutical Alliance (IPA) questions the reliance on the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) in the Ohio State University report titled, Are All Generic Drugs Created Equal? An Empirical Analysis of Generic Drug Manufacturing Location and Serious Drug Adverse Events.

article thumbnail

CPHI to return to Messe Frankfurt in 2025

Express Pharma

CPHI Europe, reportedly, the world’s largest pharmaceutical event, will return to Messe Frankfurt from October 28-30, 2025. The event will gather the entire supply chain, including ingredients, finished dosages, machinery, bio, and packaging. CPHI events highlight industry trends, with analysts predicting growth in 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

As environmental concerns continue to intensify, the pressure on the pharmaceutical industry to reduce its overall environmental impact, particularly in final dosage forms, is growing proportionately. In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants.

Dosage 104
article thumbnail

CPHI to return to Milan in 2024

European Pharmaceutical Review

CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. This year’s event marks the 20th anniversary of the CPHI Pharma Awards.

Dosage 98
article thumbnail

Sandoz granted novel biosimilars approval

European Pharmaceutical Review

Keren Haruvi, President Sandoz North America highlighted that denosumab is a medicine that can address primary and secondary bone loss, such as osteoporosis, as well as cancer-related skeletal events. Wyost Similarly, Wyost 120 mg/1.7 mL (70 mg/mL) injection is a human monoclonal antibody designed to bind to the RANKL protein.

article thumbnail

From Healing to Harm: The Unintended Consequences of Polypharmacy in Seniors

PharmD Live

People over 65 make up only 14% of the population but account for 56% of hospitalizations for adverse drug events (ADEs) (Agency for Healthcare Research and Quality, AHRQ, 2021). Healthcare providers review medication lists, adjust dosages, and coordinate care among multiple specialists. References: Budnitz, D. Lovegrove, M.

article thumbnail

How Pharmacogenomics may finally realise its promise

pharmaphorum

These drugs have been rigorously tested by regulatory bodies around the world before they’re made available to ensure they work as labelled, but despite that, adverse events crop up. Looking at an individual’s genomic profile also provides an understanding of appropriate medication dosage. billion in the United States alone.

Dosage 98